UK Markets closed

MorphoSys AG (MOR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
5.03-0.37 (-6.85%)
At close: 04:00PM EDT
5.03 0.00 (0.00%)
After hours: 05:32PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close5.40
Open5.11
Bid5.01 x 1000
Ask5.50 x 900
Day's range5.00 - 5.15
52-week range4.07 - 12.45
Volume32,582
Avg. volume45,187
Market cap686.917M
Beta (5Y monthly)0.87
PE ratio (TTM)5.62
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Motley Fool

    MorphoSys AG (MOR) Q2 2022 Earnings Call Transcript

    At this time, I would like to turn the conference over to Julia Neugebauer. My name is Julia Neugebauer, head of investor relations at MorphoSys, and it is my pleasure to welcome you to our half year 2022 financial results conference call. With me on the call today are Jean-Paul Kress, chief executive officer; Sung Lee, chief financial officer; Malte Peters, chief research and development officer; and Joe Horvat, U.S. general manager.

  • Zacks

    MorphoSys (MOR) Gains on Oncology Collaboration With Pfizer

    MorphoSys (MOR) and Pfizer collaborate to develop a combination of MOR's Monjuvi and Pfizer's checkpoint inhibitor candidate, TTI-622, for treating r/r DLBCL.

  • Motley Fool

    MorphoSys AG (MOR) Q1 2022 Earnings Call Transcript

    My name is Julia Neugebauer, senior director investor relations at MorphoSys, and it is my pleasure to welcome you to our first quarter 2022 financial results conference call. Joining me on the call today are Jean-Paul Kress, chief executive officer; Sung Lee, chief financial officer; Malte Peters, chief research and development officer; and Joe Horvat, U.S. general manager.